Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Revenue: 2016-2024

Historic Revenue for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $482.0 million.

  • Organogenesis Holdings' Revenue rose 30.98% to $150.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $465.2 million, marking a year-over-year increase of 2.24%. This contributed to the annual value of $482.0 million for FY2024, which is 11.29% up from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Revenue is $482.0 million, which was up 11.29% from $433.1 million recorded in FY2023.
  • Organogenesis Holdings' Revenue's 5-year high stood at $482.0 million during FY2024, with a 5-year trough of $338.3 million in FY2020.
  • For the 3-year period, Organogenesis Holdings' Revenue averaged around $455.4 million, with its median value being $450.9 million (2022).
  • In the last 5 years, Organogenesis Holdings' Revenue surged by 38.15% in 2021 and then decreased by 3.94% in 2023.
  • Organogenesis Holdings' Revenue (Yearly) stood at $338.3 million in 2020, then soared by 38.15% to $467.4 million in 2021, then fell by 3.52% to $450.9 million in 2022, then fell by 3.94% to $433.1 million in 2023, then grew by 11.29% to $482.0 million in 2024.